跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Vexel-300 - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Vexel-300
Approved
STANDARD
Vexel-300
Admac Lifesciences
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
d15de4adb119fa34
Company
Admac Lifesciences
Type
Standard
Approval Details
Approval Id
d15de4adb119fa34
Drug Approval Philippines Name
Vexel-300
Product Name
Vexel-300
Registration Number
DR-XY43923
Brand Name
Vexel-300
Generic Name
Paclitaxel
Dosage Form
Concentrate For Solution For Iv Infusion
Dosage Strength
6mg/mL (300mg/50mL)
Manufacturer
Admac Lifesciences
Importer
VE Pharma Inc.
Distributor
VE Pharma Inc.
Issuance Date
29 February 2024
Expiry Date
01 December 2029
Pharmacologic Category
Antineoplastic
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
d15de4adb119fa34
Type
Standard
Back to Philippines FDA Approvals